These medications are FDA-approved and have been studied extensively for both weight loss and diabetes control
The benefits of GLP1-RA to reduce ASCVD were at least as large among people with estimated glomerular filtration rate (eGFR) 6.5%, who were at high cardiovascular risk or had established CVD (Table 1) [37], [38], [39], [40], [41]
These pathways have simultaneously developed for organ-specific adaptation to meet the physiological demands specific to each organ, sensing glucose in pancreatic -cells for insulin secretion, and sensing various nutrients like amino acids, fatty acids, and glucose for GLP-1 secretion in intestinal L-cells 32
Maintenance and Long-Term Use For those who have already reached their goal weight, the conversation shifts
GLP-1 agonists have earned their place in modern medicine